Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream

Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream

Named after the two-faced Roman god of doorways, Janus kinases (JAKs) represent a class of tyrosine kinases. The JAK signaling pathway is pivotal for the downstream signaling of inflammatory cytokines, including interleukins, interferons, and multiple growth factors. This article provides an overvie...

Full description

Bibliographic Details
Main Authors: Paul Smith, Wenqing Yao, Stacey Shepard, Maryanne Covington, Jim Lee, Jennifer Lofland, Ahmad Naim, Trupti Sheth, Bhavnish Parikh, Swamy Yeleswaram
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Pharmaceutics
Subjects:
Janus kinase
inflammation
atopic dermatitis
vitiligo
topical
Online Access:https://www.mdpi.com/1999-4923/13/7/1044

Internet

https://www.mdpi.com/1999-4923/13/7/1044

Similar Items